Solid Dispersion to Improve Dissolution of Drug Product

摘要

The term ‘solid dispersion’ has been utilized to describe a family of dosage forms whereby the drug is dispersed in a biologically inert matrix, usually with a view to enhancing oral bioavailability. It may be defined as the dispersion of one or more active ingredients in an inert carrier matrix at solid-state prepared by the melting (fusion), solvent or melting-solvent method. In practice, these dosage forms have been traditionally regarded as being synonymous with systems whereby the in vitro release of the drug is enhanced compared to conventional dosage forms, with concomitant implications for in vivo release. Furthermore, the carrier used has, again traditionally, been a water-soluble or water-miscible polymer such as polyethylene glycol (PEG) or polyvinylpyrrolidone (PVP) or low molecular weight materials such as sugars. However, the proliferation of publications in the area since the first solid dispersions were described1 has led to a broadening of these definitions to include water insoluble matrices such as Gelucires and Eudragits that may yield either slow or rapid release or absorption. DOI: http://dx.doi.org/10.3329/ijpls.v2i1.15134 International Journal of Pharmaceutical and Life Sciences Vol.2(1) 2013: 42-58